Management of Subcutaneous Hematomas: Compression and Cold Therapy Protocol
Apply a pressure dressing combined with localized cold therapy immediately to promote hematoma reabsorption. This approach reduces hematoma size more effectively than compression or cold therapy alone, with evidence showing cold compression reduces hematoma size by approximately 20 cm² over 3 hours compared to only 10 cm² with compression alone 1, 2.
Immediate Management Algorithm
Step 1: Apply Cold Therapy First (Within 6-12 Hours of Injury)
- Use an ice-water mixture in a plastic bag or instant cold pack wrapped in a thin towel or cloth barrier to prevent direct skin contact and frostbite 2.
- Apply for 20-30 minutes per session, or 10 minutes if 20 minutes is uncomfortable 2.
- Repeat applications 3-4 times daily during the acute phase (first 6-12 hours) to limit ongoing bleeding and hematoma expansion through vasoconstriction 2.
- Never apply ice directly to skin without a barrier, as this causes cold injury 2.
Rationale: Cold therapy achieves vasoconstriction that reduces blood extravasation by 357 mL and total blood loss by 610 mL compared to no cold therapy 1. The evidence, though very-low-quality, consistently demonstrates benefit in reducing femoral hematoma formation in post-procedural patients 1.
Step 2: Apply Compression Dressing
After or during cold application, apply a pressure dressing using elastic adhesive compression bandaging 1, 2, 3.
Compression Technique:
- Place 4x4 gauze pads directly over the hematoma site as a contact layer 3.
- Wrap an elastic adhesive bandage (such as Coban or similar elastic adhesive dressing) around the affected area with sufficient tension to achieve compression without compromising distal circulation 3, 4, 5.
- Target pressure of 80-90 mmHg at the wound surface—elastic adhesive dressings generate average pressures of 88 mmHg compared to only 33 mmHg with standard field dressings 5.
- Maintain the pressure dressing for 12-24 hours after initial application 1.
Rationale: Elastic adhesive compression dressings are superior to standard gauze wrapping because they maintain consistent pressure, are hands-free, and work effectively across diverse body surfaces 3, 6, 5. Research demonstrates elastic adhesive dressings provide significantly higher compression pressures than conventional field dressings (88 mmHg vs 33 mmHg), which is critical for promoting hematoma reabsorption 5.
Step 3: Elevation (If Feasible)
- Elevate the affected extremity above heart level when possible, though evidence for this intervention is limited 2.
Critical Timing Considerations
- Cold therapy is specifically for the acute phase only (first 6-12 hours after injury) 2.
- Never apply heat in the acute phase, as it increases bleeding and swelling 2.
- Begin treatment as soon as possible after hematoma formation for maximum benefit 2.
Monitoring and Follow-Up
Assess for Complications Requiring Emergency Care:
- Expanding hematoma near major vessels 2
- Blue or extremely pale extremity distal to the hematoma 2
- Loss of pulses or compromised perfusion 2
- Severe pain suggesting compartment syndrome 7
When to Evacuate Rather Than Compress:
Evacuate the hematoma surgically only when there is increased tension on the skin that threatens skin integrity 1. Otherwise, avoid needle aspiration, as this introduces skin flora and increases infection risk 1, 7.
Common Pitfalls to Avoid
- Do not remove the dressing prematurely to check the hematoma, as this disrupts clot formation 2, 7.
- Do not apply cold for longer than 30 minutes continuously to prevent tissue damage 2.
- Do not use narrow tourniquets for compression, as they cause more pain and tissue damage 7.
- Do not apply heat during the acute phase, as it is explicitly contraindicated and inferior to cold application 2.
Evidence Quality Note
The recommendation for combined cold therapy and compression is based on very-low-quality evidence from small RCTs in post-procedural settings (cardiac catheterization, knee arthroplasty) 1. However, the consistent direction of benefit across studies, combined with the low risk of harm when applied correctly, supports this approach in real-world clinical practice 1, 2.